| Literature DB >> 29659509 |
Dayoung Kim1, Eun Ju Lee2, Jihye Lee3, Alain S Leutou4, Yern-Hyerk Shin5, Bomi Choi6, Ji Sun Hwang7, Dongyup Hahn8,9, Hyukjae Choi10, Jungwook Chin11, Sung Jin Cho12, Yong Deog Hong13, Jaeyoung Ko14, Chi Nam Seong15, Katherine N Maloney16, Dong-Chan Oh17, Inho Yang18, Hayoung Hwang19, Sang-Jip Nam20.
Abstract
Antartin (1), a new zizaane-type sesquiterpene, was isolated from Streptomyces sp. SCO736. The chemical structure of 1 was assigned from the interpretation of 1D and 2D NMR in addition to mass spectrometric data. The relative stereochemistry of 1 was determined by analysis of NOE data, while the absolute stereochemistry was decided based on a comparison of experimental and calculated electronic circular dichroism (ECD) spectra. Antartin (1) showed cytotoxicity against A549, H1299, and U87 cancer cell lines by causing cell cycle arrest at the G1 phase.Entities:
Keywords: Streptomyces sp.; cold water natural product; marine natural product; zizaane-type sesquiterpenoid
Mesh:
Substances:
Year: 2018 PMID: 29659509 PMCID: PMC5923417 DOI: 10.3390/md16040130
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structure of compound 1.
NMR spectroscopic data for antartin (1) 1 in methanol-d4.
| Position | δc, Type 2 | δH, ( | COSY | HMBC |
|---|---|---|---|---|
| 1 | 54.2, qC | |||
| 2 | 38.7, CH | 2.07, m | 3a, 12 | 1, 3, 10, 11, 12 |
| 3a | 41.7, CH2 | 1.49, m | 2, 4 | 2, 12 |
| 3b | 1.83, m | 4, 5 | ||
| 4 | 53.9, CH | 4.24, d (6.1) | 3a | 1, 2, 5, 6, 1′ |
| 5 | 146.8, qC | |||
| 6 | 136.4, qC | |||
| 7 | 42.4, qC | |||
| 8 | 49.1, CH | 1.90, m | 9a, 9b, 10, 11 | 1, 6 |
| 9a | 25.8, CH2 | 1.67, m | 8, 10a | 1, 8, 11 |
| 9b | 1.84, m | 8, 10b | ||
| 10a | 30.8, CH2 | 1.28, br | 9a | |
| 10b | 1.48, m | 9b | 1, 5, 8 | |
| 11 | 38.6, CH2 | 1.60, d (3.0) | 8 | 1, 5, 7, 8, 9, 10 |
| 12 | 14.3, CH3 | 0.94, d (6.8) | 2 | 1, 2, 3 |
| 13 | 14.0, CH3 | 1.52, s | 5, 6, 7 | |
| 14 | 25.7, CH3 | 1.04, s | 6, 7, 8, 15 | |
| 15 | 29.6, CH3 | 1.10, s | 6, 7, 8, 14 | |
| 1′ | 152.1, qC | |||
| 2′ | 111.9, qC | |||
| 3′ | 133.7, CH | 7.85, dd (6.9, 2.0) | 4′ | 1′, 5′, 6′, 7′ |
| 4′ | 115.3, CH | 6.51, dd (6.9, 6.9) | 3′, 5′ | 2′, 3′, 5′, 6′ |
| 5′ | 135.5, CH | 7.31, dd (6.9, 6.9) | 4′, 6′ | 1′, 3′, 6′ |
| 6′ | 113.0, CH | 6.69, dd (6.9, 2.0) | 5′ | 2′, 4′, 7′ |
| 7′ | 172.5, qC |
1 500 MHz for 1H NMR and 125 MHz for 13C NMR. 2 Multiplicity was determined by the analysis of 2D NMR spectroscopic data.
Figure 2COSY and key HMBC correlations (a), and NOESY correlations (b) of antartin (1).
Figure 3Electronic circular dichroism (ECD) spectrum for antartin (1).
The effect of antartin (1) on cancer cell proliferation 1.
|
|
|
|
| |||
|
|
|
|
|
|
| |
| DMSO | 100 ± 4 | 100 ± 6.4 | 100 ± 1.6 | 100 ± 3.8 | 100 ± 3.8 | 100 ± 3.5 |
|
| 24.8 ± 4.5 | 12.2 ± 0.8 | 1.6 ± 0.4 | 13.9 ± 4.1 | 14.2 ± 4 | 63.2 ± 4.9 |
|
|
|
|
|
| ||
|
|
|
|
|
|
| |
| DMSO | 100 ± 5.1 | 100 ± 12.9 | 100 ± 4.0 | 100 ± 2.6 | 100 ± 2.6 | 100 ± 2.4 |
|
| 20.5 ± 5.1 | 4.1 ± 3.6 | 0.8 ± 1.4 | 0.2 ± 0.0 | 0.4 ± 0.1 | 14.1 ± 2.8 |
1 Cell proliferation is shown as % of remaining cells after treatment of 1 at 20 μg/mL for 48 h compared with DMSO-treated cells, which is designated as % of viable cells ± STDEV. 2 Non-small-cell lung carcinoma.
Figure 4Effect of compound 1 on the growth of lung cancer cells and brain tumor cells. (a) Focus-forming assay. The absence of foci in the 1-treated cells suggests that 1 suppressed lung cancer cell tumorigenic potential; (b) Cell growth assay. Cancer cell growth in real time was monitored for four days after treatment with 1, showing no cell growth (Blue dot: 0.2% DMSO, Red dot: 10 μg/mL 1); (c) Immunofluorescence staining experiment. In 1-treated cells, the expression of Ki-67, a representative proliferation marker, disappeared.
Figure 5Cell cycle arrest by treatment with 1. (a) Lung cancer cells (A549 and H1299) and brain tumor cells (U87) showed cell cycle arrest at the G1 phase after treatment with 1; (b) Western blot analysis of cell cycle-associated proteins revealed that 1 downregulated the expressions of cell cycle transit proteins from the G1 to S phases, resulting in G1 arrest.